Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

20.54 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Breaking Down Kenvue: 8 Analysts Share Their Views
 
Via Benzinga
Kenvue (KVUE) Q4 2024 Earnings Call Transcript
KVUE earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Kenvue's Q4 Sales Miss, Margins Improve
Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and Beauty segment. 
Via The Motley Fool
Topics Earnings
Kenvue Reports Full Year and Fourth Quarter 2024 Results
From Kenvue
Via Business Wire
Earnings Scheduled For February 6, 2025
 
Via Benzinga
Kenvue Highlights Commitment to Shareholder Value
From Kenvue
Via Business Wire
A Look Into Kenvue Inc's Price Over Earnings
 
Via Benzinga
What Analysts Are Saying About Kenvue Stock
 
Via Benzinga
Peering Into Kenvue's Recent Short Interest
 
Via Benzinga
All It Takes Is $3,000 Invested in Each of These 3 Ultra-Reliable Dividend King Stocks to Help Generate Over $300 in Passive Income in 2025
Via The Motley Fool
Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?
Via The Motley Fool
Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025
From Kenvue
Via Business Wire
These Dividend Stocks Fell Between 1% and 20% in 2024. Here's Why They Are Too Cheap to Ignore and Worth Buying in 2025.
Via The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors. 
Via The Motley Fool
Critical Insights From Kenvue Analyst Ratings: What You Need To Know
 
Via Benzinga
How Is The Market Feeling About Kenvue?
 
Via Benzinga
In-Depth Technical Analysis of KENVUE INC.
With a solid technical rating of 8 out of 10, KENVUE INC (NYSE:KVUE) is showing strong indications of a possible breakout. 
Via Chartmill
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company
Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential... 
Via Benzinga
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
10 One Decision Stocks To Buy Now
The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats. 
Via Talk Markets
Topics Stocks / Equities
10 Conservative Retirement Income Stocks To Buy Now
Conservative retirement investing is all about creating passive income with quality securities, held for the long-run. 
Via Talk Markets
Topics Retirement Stocks / Equities
3 Dividend-Paying Value Stocks to Buy Even If There's a Stock Market Sell-Off in 2025
Investing by equal parts in these three dividend stocks produces an average yield of 3%. 
Via The Motley Fool
A Bull Market Is Here: 2 Super Stocks Down 21% and 30% to Buy Right Now
Via The Motley Fool
Coca-Cola cs. Procter & Gamble: Which Is the Better Dow Dividend King Stock to Buy Before the End of the Year?
Via The Motley Fool
Topics Stocks
Like Passive Income? Then You'll Love These 3 Super Safe Dividend Stocks That Are Up Between 28% and 42% in 6 Months.
These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years. 
Via The Motley Fool
Kenvue Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
From Kenvue
Via Business Wire
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued. 
Via Benzinga
Kenvue (KVUE) Q3 2024 Earnings Call Transcript
KVUE earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales
Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in Skin Health and Beauty. 
Via Benzinga
Kenvue Reports Third Quarter 2024 Results
From Kenvue
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.